Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

© 2026 Go Backs. All rights reserved.

Low RiskFDA Vet
Pets & Animals/Pet Medications

Lloyd Inc: Xylazine Hydrochloride Injection Recalled for Aseptic Manufacturing Concerns

Agency Publication Date: April 15, 2003
Share:
Sign in to monitor this recall

Summary

Lloyd Inc is recalling approximately 32,449 vials of Xylazine hydrochloride (100 mg/ml) used in veterinary medicine because the product may not have been manufactured under aseptic conditions. This recall includes the brand names AnaSed, Cervizine, Butler Xylazine-100, and nv AnaSed, all packaged in 50-ml vials. Use of a non-sterile injectable medication can lead to serious infections or adverse health outcomes in animals. Consumers who have these products should stop using them and contact their veterinarian or the manufacturer immediately.

Risk

The product may not be sterile due to a failure in aseptic manufacturing processes, which could introduce bacteria or other contaminants directly into an animal's bloodstream or tissue during injection.

What You Should Do

  1. Identify your product by checking the label for Xylazine hydrochloride (100 mg/ml) in 50-ml vials under these brand names: AnaSed Injectable (Akorn Inc.), Cervizine Injectable (Wildlife Pharmaceuticals Inc), Butler Xylazine-100 Injectable (The Butler Company), or nv AnaSed (Novopharm Limited).
  2. Stop using any affected vials immediately to prevent the risk of infection in animals.
  3. Contact your veterinarian or pharmacist to discuss alternative treatments and for guidance on how to safely handle the affected medication.
  4. Return any unused product to the place of purchase for a refund and contact Lloyd Inc at their Shenandoah, Iowa headquarters for further instructions.
  5. For additional questions or to report an adverse event, contact the FDA Center for Veterinary Medicine at 1-240-402-7002.

Your Remedy Options

💰Full Refund

Veterinary drug refund and professional consultation

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund.

Affected Products

Product: AnaSed Injectable (Xylazine hydrochloride), 100 mg/ml (50-ml vial)
Model:
NADA #139-236
V-013-4
Product: Cervizine Injectable (Xylazine hydrochloride), 100 mg/ml (50-ml vial)
Model:
NADA #139-236
V-013-4
Product: Butler Xylazine-100 Injectable (Xylazine hydrochloride), 100 mg/ml (50-ml vial)
Model:
NADA #139-236
V-013-4
Product: nv AnaSed (Xylazine hydrochloride), 100 mg/ml (50-ml vial)
Model:
NADA #139-236
V-013-4

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 26019
Status: Active
Manufacturer: Lloyd Inc
Sold By: Lloyd Laboratories; Akorn Inc.; Wildlife Pharmaceuticals Inc; The Butler Company; Vet-A-Mix; Novopharm Limited
Manufactured In: United States
Units Affected: 32,449 bottles
Distributed To: Nationwide

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response